Latest news with #Datametrex
The Market Online
a day ago
- Business
- The Market Online
Datametrex acquires Arbutus Health and Wellness, expands Canadian healthcare footprint
Datametrex AI (TSXV:DM) has acquired Arbutus Health and Wellness Inc., a multidisciplinary medical clinic for 11 million shares Arbutus offers a comprehensive range of medical services under one roof, including walk-in care, family medicine, and skin laser treatments The company plans to continue investing in healthcare innovation and infrastructure Datametrex AI Ltd. stock (TSXV:DM) last traded at $0.12 Technology and healthcare-focused company, Datametrex AI (TSXV:DM) announced the acquisition of Arbutus Health and Wellness Inc., a multidisciplinary medical clinic based in Vancouver, British Columbia. The acquisition marks a major move by Datametrex to deepen its presence in the Canadian healthcare market. Arbutus Health and Wellness offers a comprehensive range of medical services under one roof, including walk-in care, family medicine, skin laser treatments, and other specialty healthcare services. Once fully operational, the clinic will be staffed by licensed healthcare professionals, enabling patients to access multiple services without the need for multiple referrals—a model aimed at improving efficiency and patient experience. Under the terms of the agreement, Datametrex acquired 100 per cent of the issued and outstanding shares of Arbutus Health in exchange for 11 million common shares of Datametrex, valued at $0.10 per share. Arbutus is now a wholly-owned subsidiary of Datametrex. Datametrex has not assumed any debt from Arbutus as part of the transaction. The acquisition does not constitute a fundamental change to Datametrex's business operations, nor is it expected to result in a change of control of the company. 'We are excited to finalize this agreement and are eager to integrate the Arbutus Health team into Datametrex,' Datametrex's CEO, Paul Haber said in a news release. 'This acquisition marks a key milestone in broadening our product portfolio and enhancing our presence in the healthcare sector.' The company plans to continue investing in healthcare innovation and infrastructure, leveraging its technological expertise to support the clinic's operations and patient services. Datametrex develops innovative solutions across technology, artificial intelligence and healthcare to enhance operational efficiencies and business outcomes. Datametrex AI Ltd. stock (TSXV:DM) last traded at $0.12 and though it has risen more than 9 per cent this week, it has lost more than 73 per cent since June 2024. Join the discussion: Find out what everybody's saying about this potentially undervalued microcap stock on the Datametrex AI Ltd. Bullboard, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Associated Press
06-02-2025
- Business
- Associated Press
Datametrex Announces Share Consolidation
TORONTO, ON / ACCESS Newswire / February 6, 2025 / Datametrex AI Limited (the 'Company' or 'Datametrex') (TSXV:DM)(FSE:D4G)(OTCQB:DTMXF) announces a proposed consolidation of its common shares on the basis of one (1) new common share for every existing thirty (30) common shares (the 'Consolidation'), subject to regulatory approval, including approval of the TSX Venture Exchange (the 'TSXV'). The Consolidation was approved by the shareholders of the Company at the Annual and Special Meeting held on November 13, 2024. The management believes that the Consolidation is necessary to optimize the capital structure of the Company and to attract financing. Subject to approval of the TSXV, the Consolidation is anticipated to be completed in the immediate future. Where the exchange results in a fractional share, any fractional share that is less than 1/2 of one post-consolidation Common Share will be cancelled and each fractional share that is at least 1/2 of one post-consolidation Common Share will be rounded up to one whole post-consolidation Common Share. The Company's new ISIN number will be CA23809L2075. The Company will not undergo a name change at the time of Consolidation. Accordingly, the trading symbol of the Company's common shares on the TSXV will remain as 'DM'. A letter of transmittal will be mailed to registered shareholders providing instructions on how to exchange share certificates representing pre-Consolidation Shares for new share certificates or direct registration advice statements (DRS) representing post-Consolidation Shares to which they are entitled as a result of the Consolidation. No action is required by non-registered shareholders (shareholders who hold their common shares through an intermediary) to effect the Consolidation. As on date, there are 630,080,158 pre-Consolidation shares outstanding. Following the Consolidation, there are expected to be 21,002,671 post-Consolidation shares outstanding. About Datametrex Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology. For more on Datametrex, please visit our Company website. For Additional Information Paul Haber, C.P.A., C.A., C. Dir CEO & Chairman (416) 318-6501 Disclaimer Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release Forward-Looking Statements This press release may contain certain forward-looking information and statements ('forward-looking information') within the meaning of applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words 'believes', "anticipates', 'plans', 'intends', 'will', 'should', 'expects', 'continue', 'estimate', 'forecasts' and other similar expressions. Forward-looking information in this press release includes, but is not limited to, expectations regarding the Consolidation, the new ISIN of the Company being effective as of the expected effective date, and the Company receiving regulatory approvals to complete the Consolidation. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. The Company undertakes no obligation to comment analyses, expectations or statements made by third-parties in respect of the Company, its securities, or financial or operating results (as applicable). Although the Company believes that the expectations reflected in forward-looking information in this press release are reasonable, such forward-looking information has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control. The forward-looking information contained in this press release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
